Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Inovio Biomedical Corp (INO)  
$0.58 0.00 (0.00%) as of 4:30 Wed 1/24


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 169,410,000
Market Cap: 97.83(M)
Last Volume: 3,856,623 Avg Vol: 3,846,095
52 Week Range: $0.35 - $0.885
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Instruments & Supplies

Member Indexes:
    AMEX COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Inovio Pharmaceuticals is a biotechnology company focused on bringing the designed deoxyribonucleic acid (DNA) medicines and vaccines to help protect people from infectious diseases, including COVID-19, and to help treat people with cancer, and conditions associated with human papillomavirus. Co.'s DNA medicines pipeline is comprised of three types of product candidates: prophylactic DNA vaccines, therapeutic DNA immunotherapies, and DNA encoded monoclonal and bispecific antibodies, all of which utilize the two components of Co.'s integrated platform, SynCon® and CELLECTRA®. Co. is evaluating the feasibility of, conducting or planning clinical studies of its DNA medicines.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 5,700 37,076
Total Sell Value $0 $0 $3,192 $60,923
Total People Sold 0 0 1 3
Total Sell Transactions 0 0 1 5
End Date 2024-03-03 2023-12-01 2023-06-02 2022-06-02

   
Records found: 363
  Page 12 of 15  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kim Jong Joseph Chief Executive Officer   •       •      –    2018-03-10 4 OE $0.00 $0 D/D 105,700 2,321,911     -
   Bagarazzi Mark Chief Medical Officer   •       –      –    2018-03-10 4 D $4.51 $25,495 D/D (5,653) 81,513     -
   Bagarazzi Mark Chief Medical Officer   •       –      –    2018-03-10 4 OE $0.00 $0 D/D 20,434 87,166     -
   Weiner David B. Director   –       •      –    2018-03-10 4 OE $0.00 $0 D/D 11,667 767,956     -
   Sardesai Niranjan Chief Operating Officer   •       –      –    2018-03-09 4 D $4.51 $31,101 D/D (6,896) 108,705     -
   Sardesai Niranjan Chief Operating Officer   •       –      –    2018-03-09 4 OE $0.00 $0 D/D 25,000 115,601     -
   Kies Peter CFO   •       –      –    2018-03-09 4 D $4.51 $37,979 D/D (8,421) 68,553     -
   Kies Peter CFO   •       –      –    2018-03-09 4 OE $0.00 $0 D/D 25,000 76,974     -
   Kim Jong Joseph Chief Executive Officer   •       •      –    2018-03-09 4 D $4.51 $71,907 D/D (15,944) 2,216,211     -
   Kim Jong Joseph Chief Executive Officer   •       •      –    2018-03-09 4 OE $0.00 $0 D/D 57,333 2,232,155     -
   Bagarazzi Mark Chief Medical Officer   •       –      –    2018-03-09 4 D $4.51 $31,101 D/D (6,896) 66,732     -
   Bagarazzi Mark Chief Medical Officer   •       –      –    2018-03-09 4 OE $0.00 $0 D/D 25,000 73,628     -
   Weiner David B. Director   –       •      –    2018-03-09 4 OE $0.00 $0 D/D 15,333 756,289     -
   Bagarazzi Mark Chief Medical Officer   •       –      –    2018-03-05 4 D $4.29 $12,076 D/D (2,815) 48,628     -
   Bagarazzi Mark Chief Medical Officer   •       –      –    2018-03-05 4 OE $0.00 $0 D/D 8,333 51,443     -
   Kies Peter CFO   •       –      –    2018-03-05 4 D $4.29 $14,616 D/D (3,407) 51,974     -
   Kies Peter CFO   •       –      –    2018-03-05 4 OE $0.00 $0 D/D 8,333 55,381     -
   Kim Jong Joseph Chief Executive Officer   •       •      –    2018-03-05 4 D $4.29 $15,920 D/D (3,711) 2,174,822     -
   Kim Jong Joseph Chief Executive Officer   •       •      –    2018-03-05 4 OE $0.00 $0 D/D 13,333 2,178,533     -
   Sardesai Niranjan Chief Operating Officer   •       –      –    2018-03-05 4 D $4.29 $12,076 D/D (2,815) 90,601     -
   Sardesai Niranjan Chief Operating Officer   •       –      –    2018-03-05 4 OE $0.00 $0 D/D 8,333 93,416     -
   Kim Jong Joseph Chief Executive Officer   •       •      –    2017-07-28 4 OE $5.08 $311,531 D/D 61,325 2,165,200     -
   Weiner David B. Director   –       •      –    2017-05-25 4 S $8.00 $64,016 D/D (8,000) 740,956     -
   Mahmoud Adel Director   –       •      –    2017-05-13 4 OE $0.00 $0 D/D 10,000 15,000     -
   Collins Morton Director   –       •      –    2017-05-13 4 OE $0.00 $0 D/D 10,000 152,291     -
  363 Records found
  Previous  10  11  12  13  14  15   
  Page 12 of 15
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us